News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Shionogi & Co., Ltd. and Shionogi, Inc. Announce a Favorable Decision In FORTAMET® Preliminary Injunction Proceedings


12/7/2011 8:43:56 AM

OSAKA, Japan & FLORHAM PARK, N.J.--(BUSINESS WIRE)--Shionogi & Co., Ltd., together with its U.S. subsidiary, Shionogi Inc. (together “Shionogi”), today announced that the U.S. District Court in New Jersey granted Shionogi’s motion for a preliminary injunction against Lupin Ltd. and its U.S. subsidiary, Lupin Pharmaceuticals, Inc. (together “Lupin”). The preliminary injunction prevents Lupin from further importing and selling a generic version of FORTAMET® before the district court renders a decision in the on-going litigation relating to U.S. Patent Nos. 6,099,859 (the “’859 Patent”) and 6,866,866 (the “’866 Patent”) covering FORTAMET®. No trial date has been set.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES